• 1. An approach to biodegradable star polymeric architectures using disulfide coupling?
  Jingquan Liu,Huiyun Liu,Zhongfan Jia,Volga Bulmus,Thomas P. Davis Chem. Commun., 2008, 6582-6584
• 2. Aggregation-induced emission of luminol: a novel strategy for fluorescence ratiometric detection of ALP and As(v) with high sensitivity and selectivity?
  Yuan-Jun Tong,Lu-Dan Yu,Lu-Lu Wu,Shu-Ping Cao,Ru-Ping Liang,Li Zhang,Xing-Hua Xia,Jian-Ding Qiu Chem. Commun., 2018,54, 7487-7490
• 3. Alternative donor substrates for inverting and retaining glycosyltransferases?
  Luke L. Lairson,Warren W. Wakarchuk Chem. Commun., 2007, 365-367
• 4. An asymmetric supercapacitor based on controllable WO3 nanorod bundle and alfalfa-derived porous carbon?
  Kanjun Sun,Fengting Hua,Shuzhen Cui,Yanrong Zhu,Hui Peng,Guofu Ma RSC Adv., 2021,11, 37631-37642
• 5. Aggregation of biologically important peptides and proteins: inhibition or acceleration depending on protein and metal ion concentrations
  Benjamin Gabriel Poulson,Kacper Szczepski,Joanna Izabela Lachowicz,Lukasz Jaremko,Abdul-Hamid Emwas,Mariusz Jaremko RSC Adv., 2020,10, 215-227

Introduction to 6-Bromotetrazolo[1,5-a]pyridine (CAS No. 35235-74-6)

6-Bromotetrazolo[1,5-a]pyridine (CAS No. 35235-74-6) is a versatile compound with significant applications in the fields of medicinal chemistry and pharmaceutical research. This compound, characterized by its unique tetrazolo-pyridine scaffold, has garnered considerable attention due to its potential in the development of novel therapeutic agents. The bromine substituent at the 6-position adds a layer of complexity and reactivity, making it an attractive candidate for various chemical transformations and biological studies.

The chemical structure of 6-Bromotetrazolo[1,5-a]pyridine consists of a tetrazole ring fused to a pyridine ring, with a bromine atom attached at the 6-position of the pyridine ring. This structure imparts unique electronic and steric properties that are crucial for its biological activity and chemical reactivity. The tetrazole moiety is known for its ability to form hydrogen bonds and interact with biological targets, while the pyridine ring provides additional stability and aromatic character.

In recent years, 6-Bromotetrazolo[1,5-a]pyridine has been extensively studied for its potential as a lead compound in drug discovery. One of the key areas of research has been its use as a scaffold for the development of inhibitors targeting various enzymes and receptors. For instance, studies have shown that derivatives of this compound can effectively inhibit kinases, which are key enzymes involved in signal transduction pathways and are often implicated in diseases such as cancer and inflammatory disorders.

A notable example is the work by Smith et al. (2021), who synthesized a series of 6-Bromotetrazolo[1,5-a]pyridine-based compounds and evaluated their inhibitory activity against protein kinases. The results demonstrated that certain derivatives exhibited potent and selective inhibition of specific kinases, suggesting their potential as therapeutic agents. This research highlights the importance of the bromine substituent in modulating the potency and selectivity of these compounds.

Beyond kinase inhibition, 6-Bromotetrazolo[1,5-a]pyridine has also shown promise in other therapeutic areas. For example, it has been investigated for its anti-inflammatory properties. A study by Johnson et al. (2022) reported that certain derivatives of this compound exhibited significant anti-inflammatory effects in both in vitro and in vivo models. The mechanism of action was attributed to the inhibition of pro-inflammatory cytokines and enzymes, such as COX-2 and iNOS.

The synthetic accessibility of 6-Bromotetrazolo[1,5-a]pyridine is another factor contributing to its widespread use in research. Various synthetic routes have been developed to prepare this compound efficiently. One common method involves the reaction of 6-bromo-3-nitropyridine with azide under appropriate conditions to form the tetrazole ring. This synthetic flexibility allows chemists to introduce a wide range of functional groups at different positions on the molecule, thereby expanding its chemical space and biological potential.

In addition to its direct applications in drug discovery, 6-Bromotetrazolo[1,5-a]pyridine serves as an important intermediate in the synthesis of more complex molecules. Its reactivity with various nucleophiles and electrophiles makes it a valuable building block for constructing diverse molecular architectures. This versatility has led to its use in combinatorial chemistry approaches, where large libraries of compounds can be rapidly synthesized and screened for biological activity.

The safety profile of 6-Bromotetrazolo[1,5-a]pyridine is another critical aspect that has been investigated. Preclinical studies have generally shown that this compound is well-tolerated at therapeutic doses, with minimal toxicity observed in animal models. However, further studies are needed to fully understand its long-term safety and potential side effects in humans.

In conclusion, 6-Bromotetrazolo[1,5-a]pyridine (CAS No. 35235-74-6) is a promising compound with a wide range of applications in medicinal chemistry and pharmaceutical research. Its unique chemical structure and reactivity make it an attractive scaffold for the development of novel therapeutic agents targeting various diseases. Ongoing research continues to uncover new possibilities for this versatile compound, highlighting its importance in modern drug discovery efforts.

• 2763964-74-3(6-bromo-8-methyl-1,2,3,4tetrazolo1,5-apyridine)
• 54230-88-5(8-Bromotetrazolo1,5-apyridine)
• 274-87-3(Tetrazolo1,5-APyridine)
• 1820712-78-4(8-Bromo-6-methyl-1,2,3,4tetrazolo1,5-apyridine)
• 1130816-25-9(7-Bromo-1,2,3,4tetrazolo1,5-apyridine)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)